BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 78 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,179,000 | -12.1% | 22,310 | +1.9% | 0.28% | -16.9% |
Q2 2020 | $1,342,000 | +9.6% | 21,899 | +1.2% | 0.33% | -12.0% |
Q1 2020 | $1,224,000 | -3.5% | 21,645 | -2.8% | 0.38% | +30.1% |
Q4 2019 | $1,268,000 | +7.1% | 22,266 | +0.7% | 0.29% | +3.2% |
Q3 2019 | $1,184,000 | -6.6% | 22,116 | +4.1% | 0.28% | -7.6% |
Q2 2019 | $1,268,000 | +95.7% | 21,244 | +1151.1% | 0.30% | +91.8% |
Q1 2019 | $648,000 | -49.3% | 1,698 | -91.9% | 0.16% | -58.9% |
Q4 2018 | $1,277,000 | +11.8% | 21,077 | +7.9% | 0.38% | +33.3% |
Q3 2018 | $1,142,000 | +31.7% | 19,525 | +1.1% | 0.29% | +27.4% |
Q2 2018 | $867,000 | +5.2% | 19,321 | +4.0% | 0.23% | +1.3% |
Q1 2018 | $824,000 | +9.3% | 18,583 | +6.8% | 0.22% | +8.8% |
Q4 2017 | $754,000 | -3.2% | 17,406 | +3.9% | 0.20% | -6.4% |
Q3 2017 | $779,000 | -4.7% | 16,753 | +1.5% | 0.22% | -8.4% |
Q2 2017 | $817,000 | -11.8% | 16,505 | -2.3% | 0.24% | -12.1% |
Q1 2017 | $926,000 | -2.4% | 16,889 | -0.9% | 0.27% | -4.9% |
Q4 2016 | $949,000 | +21.4% | 17,040 | -4.0% | 0.29% | +15.3% |
Q3 2016 | $782,000 | +12.5% | 17,741 | +2.0% | 0.25% | +8.3% |
Q2 2016 | $695,000 | – | 17,395 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|